Data as of Sep 19
| -0.06 / -1.10%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 9.83, with a high estimate of 9.83 and a low estimate of 9.83. The median estimate represents a +82.00% increase from the last price of 5.40.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.